Kura Oncology, Inc. (KURA) stock forecast and price target
Price $7.77 · data as of November 13, 2026
12-month price target
Average target$32.00
Upside / downside+311.8%
Analysts13
ConsensusStrong buy
Low $15.00Average $32.00High $76.00
Gold marker: average target · white marker: today’s price ($7.77)
Analyst ratings
Strong buy 3Buy 12Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-3.21 | −1.0% | $94M |
| Next fiscal year ends December 31, 2027 | $-2.39 | +25.6% | $200M |
| Next quarter ends December 31, 2026 | $-0.81 | +11.9% | $32M |
| Quarter after ends March 31, 2027 | $-0.69 | — | $39M |
Consensus of the analysts covering Kura Oncology, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Kura Oncology stock price target?
The average 12-month target from 13 analysts is $32.00, 311.8% above the current price of $7.77 Targets range from $15.00 to $76.00.
Is Kura Oncology a buy according to analysts?
The consensus rating is “Strong buy” (3 strong buy, 12 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Kura Oncology expected to earn?
Analysts expect EPS of $-3.21 for the fiscal year ending December 31, 2026 and $-2.39 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.